<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04410146</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-201912-SQUID</org_study_id>
    <nct_id>NCT04410146</nct_id>
  </id_info>
  <brief_title>The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)</brief_title>
  <acronym>STEM</acronym>
  <official_title>The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balt USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Balt Extrusion</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Embo-Flüssigkeiten A.G.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>AXIOM Real Time Metrics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Balt USA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      STEM Study is a pivotal, international, multi-center, prospective, randomized (1:1)&#xD;
      controlled trial designed to provide an assessment of the safety and effectiveness of Middle&#xD;
      Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural&#xD;
      Hematoma (cSDH)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study objective is to provide an assessment of the safety and effectiveness of Middle&#xD;
      Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural&#xD;
      Hematoma (cSDH).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Cognitive improvement, as measured by blinded assessment, utilizing the comprehensive neurocognitive battery.&#xD;
Imaging assessment by Imaging blinded Core laboratory</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment failure</measure>
    <time_frame>within 180-days of intervention</time_frame>
    <description>Residual or re-accumulation of the SDH (≥10 mm) or&#xD;
Re-operation (after index procedure) or surgical rescue or&#xD;
Any new, major disabling stroke after enrollment, myocardial infarction (MI) or death from any (neurological) cause</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Subdural Hematoma, Chronic</condition>
  <arm_group>
    <arm_group_label>Embolization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Middle Meningeal Artery (MMA) embolization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Embolization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Management</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SQUID</intervention_name>
    <description>Embolization of the Middle Meningeal Artery using the SQUID non-adhesive liquid embolic agent</description>
    <arm_group_label>Embolization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Burr-hole</intervention_name>
    <description>Surgical evacuation of the sub-dural hematoma</description>
    <arm_group_label>Embolization</arm_group_label>
    <arm_group_label>No Embolization</arm_group_label>
    <other_name>Twist-drill drainage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Management</intervention_name>
    <description>Standard medical management: drug treatment and/or observation</description>
    <arm_group_label>Embolization</arm_group_label>
    <arm_group_label>No Embolization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female Subject whose age is ≥ 30 at the time of consent&#xD;
&#xD;
          2. Pre-morbid mRS 0-1&#xD;
&#xD;
          3. cSDH measures ≥ 10 mm in greatest thickness&#xD;
&#xD;
          4. cSDH exerts mass effect upon the subjacent brain, as indicated by local cortical&#xD;
             flattening or midline shift&#xD;
&#xD;
          5. Imaging characteristics indicative of chronicity (≥ 50% of the volume of the&#xD;
             collection should be isodense or hypodense to normal cortical gray matter on Computed&#xD;
             Tomography (CT))&#xD;
&#xD;
          6. Subject presents with one or more of the following neurological symptoms: headache;&#xD;
             cognitive decline; speech difficulty or Aphasia; gait impairment or imbalance; focal&#xD;
             neurological deficit (weakness, paresthesia or sensory deficit involving of one or&#xD;
             more extremities or facial droop); and/or seizure&#xD;
&#xD;
          7. Subject, or his/her legally authorized representative, understands the nature of the&#xD;
             procedure, consents to participation in the study and provides a signed Informed&#xD;
             Consent Form&#xD;
&#xD;
          8. Female Subjects of child-bearing potential must be able to provide a current negative&#xD;
             urine pregnancy test and agree to an appropriate method of contraception throughout&#xD;
             the trial&#xD;
&#xD;
        10. Subject is able and willing to return to the investigational site for all follow-up&#xD;
        visits (e.g., 30-day, 90-day, 180-day and 1-year), as required per protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject with prior craniotomy or burr hole evacuation of cSDH&#xD;
&#xD;
          2. Subject requires (in the opinion of the treating surgeon) a full or mini craniotomy&#xD;
&#xD;
          3. Subject with urgent or emergent (within 1 hour of assessment) subdural hematoma&#xD;
             evacuation needed&#xD;
&#xD;
          4. Subject with a cSDH with a focal location (confined to the frontal or temporal base or&#xD;
             the inter-hemispheric space without cerebral convexity involvement)&#xD;
&#xD;
          5. cSDH &lt; 10 mm in thickness&#xD;
&#xD;
          6. cSDH without associated mass effect (no cortical flattening or midline shift)&#xD;
&#xD;
          7. &lt; 50% volume of the blood collection is isodense or hypodense to normal cortical gray&#xD;
             matter&#xD;
&#xD;
          8. cSDH developed due to underlying condition such as a vascular lesion, brain tumor,&#xD;
             arachnoid cyst, spontaneous intracranial hypotension or secondary to a previous&#xD;
             craniotomy&#xD;
&#xD;
          9. Life expectancy of &lt;1 year&#xD;
&#xD;
         10. Subject who presents with an intracranial mass other than subdural hematoma&#xD;
&#xD;
         11. Subject who presents with a meningioma with mass effect and/or ≥1 cm or currently&#xD;
             undergoing radiation therapy for carcinoma or sarcoma of the head or neck region&#xD;
&#xD;
         12. Subject with serum creatinine level &gt; 3.0 mg/dL at time of enrollment (this will&#xD;
             restrict the use of contrast) and not on dialysis&#xD;
&#xD;
         13. Subject with significant liver function impairment&#xD;
&#xD;
         14. Subject with a life-threatening allergy to radiographic contrast (unless treatment for&#xD;
             allergy is tolerated or can be managed medically)&#xD;
&#xD;
         15. Subject who is currently participating in another clinical research study&#xD;
&#xD;
         16. Subject who is unable to complete the required follow-up&#xD;
&#xD;
         17. Female Subject who is pregnant and/or breastfeeding&#xD;
&#xD;
         18. Subject who has participated in a drug study within the last 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Fiorella, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adam Arthur, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmes-Murphy Neurologic and Spine Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippa Hill</last_name>
    <phone>+1 909 287 9659</phone>
    <email>philippa.hill@baltgroup.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Egon Wülfert, BPharm</last_name>
    <phone>+32 470 187 887</phone>
    <email>egon.wulfert@baltgroup.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe Albuquerque, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riverside Community Hospital</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Stout, MD/ PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alois Zauner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital and Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>92360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad A Taqi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benajmin Atchie, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Hanel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Grossberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wellstar Kennestone Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rishi Gupta, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Caplan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Overlook Medical Center</name>
      <address>
        <city>Summit</city>
        <state>New Jersey</state>
        <zip>07901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Benitez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allan Brook, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook University</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fiorella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Health Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17918</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ephraim Church, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stavropoula Tjoumakaris, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan McTaggart, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Methodist University Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Hoit, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Nickele, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Cherry Hill</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Monteith, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SoHyun Boo, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jennifer Domico</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chu Cote de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Barbier, Dr. Med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hopital Bicetre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Spelle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Clarencon, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hopital Maison Blanche</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Pierot</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine JOHNSON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Nurnberg Sud</name>
      <address>
        <city>Nurnberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus HOLTMANNSPÖTTER, Dr. Med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gregorio Maranon Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Odene</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 27, 2020</study_first_submitted>
  <study_first_submitted_qc>May 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2020</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Meningeal Arteries</keyword>
  <keyword>Intracranial Subdural Hematoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma, Subdural</mesh_term>
    <mesh_term>Hematoma, Subdural, Chronic</mesh_term>
    <mesh_term>Hematoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

